| Name of Lender |
Facility/Instrument |
Amount (Rs. Crore) |
|
ICICI Bank Limited
|
Term Loans
|
6.4 |
|
Tata Capital Financial Services Limited
|
Term Loans
|
8.2 |
|
HDFC Bank Limited
|
Term Loans
|
20 |
|
ICICI Bank Limited
|
Working Capital Facilities
|
30 |
|
HDFC Bank Limited
|
Working Capital Facilities
|
10 |
|
ICICI Bank Limited
|
Working Capital Facilities
|
301
|
*June 11, 2024
1 Sublimit of long-term fund-based limits
The details presented on this page provide an update on the names of lenders, in reference to the total credit facilities of Naari Pharma Pvt. Ltd. rated by ICRA. To access the previous rating rationale: Click Here.
This update is being published as per the directions of the Reserve Bank of India (RBI) to the Credit Rating Agencies (CRAs) vide the communication [CO.DOR.ISG.No.S150/21-06-008/2021-2022] dated June 4, 2021.
